Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Ann Oncol
.
2016 Sep;27(suppl 5):v111-v118.
doi: 10.1093/annonc/mdw325.
Authors
J Klastersky
1
,
J de Naurois
2
,
K Rolston
3
,
B Rapoport
4
,
G Maschmeyer
5
,
M Aapro
6
,
J Herrstedt
7
;
ESMO Guidelines Committee
Affiliations
1
Institut Jules Bordet-Centre des Tumeurs de l'ULB, Brussels, Belgium.
2
St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK.
3
M.D. Anderson Cancer Center, Houston, TX, USA.
4
Medical Oncology Centre of Rosebank, Johannesburg, South Africa.
5
Department of Hematology, Oncology and Palliative Care, Ernst von Bergmann Hospital, Potsdam, Germany.
6
Multidisciplinary Institute of Oncology, Clinique de Genolier, Genolier, Switzerland.
7
Department of Oncology, Odense University Hospital (OUH), Odense, Denmark.
PMID:
27664247
DOI:
10.1093/annonc/mdw325
No abstract available